Virtus ETF Advisers’s AbbVie ABBV Stock Holding History

Virtus ETF Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Sell	1,056 -44	-4%	-$9.47K	0.1%	228
2026 Q1	$239K	Sell	1,100 -264	-19%	-$58.6K	0.11%	207
2025 Q4	$312K	Buy	1,364 +423	+45%	+$96.4K	0.15%	164
2025 Q3	$218K	Buy	941 +897	+2,039%	+$183K	0.12%	204
2025 Q2	$8.17K	Hold	44	–	–	0.01%	423
2025 Q1	$9.22K	Buy	+44	New	+$8.55K	0.01%	391
2023 Q3	–	Sell	-4,785	Closed	-$645K	–	436
2023 Q2	$645K	Sell	4,785 -1,189	-20%	-$174K	0.38%	121
2023 Q1	$952K	Buy	5,974 +721	+14%	+$110K	0.52%	34
2022 Q4	$849K	Buy	5,253 +655	+14%	+$100K	0.44%	48
2022 Q3	$617K	Sell	4,598 -146	-3%	-$21K	0.25%	163
2022 Q2	$727K	Buy	+4,744	New	+$725K	0.27%	107
2020 Q2	–	Sell	-167	Closed	-$13K	–	443
2020 Q1	$13K	Sell	167 -211	-56%	-$18K	0.01%	364
2019 Q4	$33K	Buy	+378	New	+$31.4K	0.01%	312

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Virtus ETF Advisers's ABBV Position: Q2 2026 in Review

Virtus ETF Advisers reduced its AbbVie (ABBV) stake by 4% in Q2 2026, selling an estimated $9.47K and leaving 1,056 shares worth $266K. The position accounts for 0.1% of the portfolio, ranked #228.

Virtus ETF Advisers first reported a position in ABBV in Q4 2019 and has held it in 13 quarters since. The position peaked at $952K in Q1 2023. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Virtus ETF Advisers held 1,056 shares of AbbVie worth $266K as of Q2 2026.
Virtus ETF Advisers sold 44 AbbVie shares in Q2 2026, an estimated $9.47K.
AbbVie made up 0.1% of Virtus ETF Advisers's portfolio in Q2 2026, its #228 holding.
Virtus ETF Advisers first reported a position in AbbVie in Q4 2019 and has held it in 13 quarters since.
Virtus ETF Advisers's AbbVie position peaked at $952K in Q1 2023.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.